Pathfinder Cell Therapy (Pathfinder Cell Therapy) Additional Paid-In Capital : $11.83 Mil(As of Sep. 2015)

View and export this data going back to . Start your Free Trial

What is Pathfinder Cell Therapy Additional Paid-In Capital?

Pathfinder Cell Therapy's quarterly additional paid-in capital stayed the same from Mar. 2015 ($11.83 Mil) to Jun. 2015 ($11.83 Mil) and stayed the same from Jun. 2015 ($11.83 Mil) to Sep. 2015 ($11.83 Mil).

Pathfinder Cell Therapy's annual additional paid-in capital increased from Dec. 2012 ($11.82 Mil) to Dec. 2013 ($11.83 Mil) and increased from Dec. 2013 ($11.83 Mil) to Dec. 2014 ($11.83 Mil).

Pathfinder Cell Therapy Additional Paid-In Capital Historical Data

The historical data trend for Pathfinder Cell Therapy's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pathfinder Cell Therapy Additional Paid-In Capital Chart

Pathfinder Cell Therapy Annual Data

Trend

Dec05

Dec06

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Additional Paid-In Capital

Get a 7-Day Free Trial

0.29

11.81

11.82

11.83

Pathfinder Cell Therapy Quarterly Data
	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15
Additional Paid-In Capital	Get a 7-Day Free Trial															11.83	11.83	11.83	11.83	11.83

Pathfinder Cell Therapy Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Pathfinder Cell Therapy Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Pathfinder Cell Therapy's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Pathfinder Cell Therapy (Pathfinder Cell Therapy) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pathfinder Cell Therapy Inc (OTCPK:PFND) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

12 Bow Street, Cambridge, MA, USA, 02138

Website

http://www.pathfindercelltherapy.com

Pathfinder Cell Therapy Inc is a regenerative medicine company. It is engaged in developing novel cell-based and related therapies for the treatment of diabetes, renal diseases and medical conditions characterized by organ-specific cell damage. Further, the group has discovered a new mammalian cell type, which is able to stimulate damaged tissues to regenerate without the Pathfinder Cells ("PCs") themselves being incorporated into the new tissue. Geographically the business activities are functioned through the region of United States.

Executives

John J Alam	director	130 WAVERLY STREET, CAMBRIDGE MA 02139
John L Brooks	director	100 LOWDER BROOK DRIVE SUITE 2500, WESTWOOD MA 02090

Pathfinder Cell Therapy (Pathfinder Cell Therapy) Headlines

No Headlines